The Latest Breaking News from European Union

In June, the U.S. Food and Drug Administration (FDA) approved Gilead Sciences, Inc.'s (NASDAQ:GILD) Yeztugo (lenacapavir) as pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV in adults and adolescents weighing at least 35kg, making it the first and only twice-yearly option available in the U.S. for people who need or…

Broadcom (NASDAQ:AVGO) is facing legal scrutiny over its $61 billion acquisition of VMware, as European Union judges assess a challenge to the deal’s approval filed by a cloud computing group.

Inhalers may be small, but they can make a big impact on the environment.

The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV

An expert committee recommended that the drug be offered to a narrow group of patients with early-stage Alzheimer’s disease.

The ambitious project was a win for Europe. Now it's resigned to wishful thinking.

Germany’s Volkswagen cut its financial guidance for 2025 after US tariffs took a €1.3 billion toll on its income in the first six months. But European sales and EVs appear to support future growth.

Meta on Friday said it will be forced to ban political advertising on its platforms in the European Union from October because of rules the Facebook and Instagram owner called "unworkable".

The EU’s transparency rules for political advertising, aimed at restricting foreign interference, will apply as of 10 October.